Summary Keywords drug-repositioning, thyroid-cancer, anti-diabetic, metformin, diabetes Citation Greco A, Coperchini F, Croce L, Magri F, Teliti M and Rotondi M (2023) Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
Having received approval for the treatment of obesity in June 2021, semaglutide 2.4 mg ushered in a new era of weight loss therapies with the FDAs recognition of the benefit shown in the STEP trials
Alumni & Impact Since inception, UNAM has produced over 70,000 graduates serving public, private, and civil sectors across Namibia and beyond
Schedule a Consultation About Dr Sherif Awad Dr Sherif is a leading experienced Consultant General, Laparoscopic, Upper Gastrointestinal and Weight Loss Surgeon based at Emirates Speciality Hospital (Healthcare City).